Colgate-Palmolive (NYSE:CL) PT Raised to $85.00 at Barclays

Colgate-Palmolive (NYSE:CL) had its price target lifted by equities research analysts at Barclays from $84.00 to $85.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Barclays‘s target price would suggest a potential downside of 7.51% from the company’s previous close.

Other research analysts also recently issued research reports about the stock. Morgan Stanley raised their price target on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a research note on Monday, January 29th. Citigroup raised their price target on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, April 16th. Royal Bank of Canada raised their price target on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research note on Monday. Evercore ISI raised their price target on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research note on Monday, April 8th. Finally, TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, January 26th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $91.44.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $91.90 on Tuesday. The firm has a 50-day moving average price of $88.08 and a 200-day moving average price of $81.99. The firm has a market capitalization of $75.40 billion, a PE ratio of 29.08, a price-to-earnings-growth ratio of 3.37 and a beta of 0.42. The company has a current ratio of 1.06, a quick ratio of 0.28 and a debt-to-equity ratio of 13.21. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $92.54.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.04. The firm had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business’s revenue was up 6.2% on a year-over-year basis. During the same quarter last year, the business earned $0.73 EPS. As a group, equities research analysts forecast that Colgate-Palmolive will post 3.52 EPS for the current year.

Insider Transactions at Colgate-Palmolive

In other news, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the transaction, the chief executive officer now owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CEO Noel R. Wallace sold 69,948 shares of Colgate-Palmolive stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total value of $5,891,020.56. Following the completion of the sale, the chief executive officer now directly owns 286,881 shares in the company, valued at approximately $24,161,117.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The disclosure for this sale can be found here. Insiders have sold a total of 159,048 shares of company stock valued at $13,336,846 in the last 90 days. Insiders own 0.37% of the company’s stock.

Institutional Trading of Colgate-Palmolive

Institutional investors have recently bought and sold shares of the stock. Kingswood Wealth Advisors LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter valued at approximately $880,000. Xponance Inc. lifted its stake in Colgate-Palmolive by 25.2% during the 3rd quarter. Xponance Inc. now owns 169,433 shares of the company’s stock valued at $12,048,000 after acquiring an additional 34,154 shares during the period. Dakota Wealth Management lifted its stake in Colgate-Palmolive by 73.3% during the 3rd quarter. Dakota Wealth Management now owns 8,573 shares of the company’s stock valued at $610,000 after acquiring an additional 3,627 shares during the period. FinTrust Capital Advisors LLC lifted its stake in Colgate-Palmolive by 46.2% during the 3rd quarter. FinTrust Capital Advisors LLC now owns 5,140 shares of the company’s stock valued at $366,000 after acquiring an additional 1,625 shares during the period. Finally, Raymond James & Associates lifted its stake in Colgate-Palmolive by 1.2% during the 3rd quarter. Raymond James & Associates now owns 900,300 shares of the company’s stock valued at $64,020,000 after acquiring an additional 10,446 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.